Not checkedNot checked for notices yet.
Egr-1 mediates the suppressive effect of IL-1 on PPARγ expression in human OA chondrocytes
Nebbaki Salwa, Ezzahra El Mansouri Fatima, Zayed Nadia and 4 more
Journal of Translational Medicine · 2012
doi:10.1186/1479-5876-10-s3-p39 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background Peroxisome proliferator-activated receptor gamma (PPARg) is a ligand activated transcription factor and member the nuclear hormone receptor superfamily. Several lines of evidence indicate that PPARg have protective effects in osteoarthritis (OA). Indeed, PPARg has been shown to down-regulate several inflammatory and catabolic responses in articular cartilage and chondrocytes and to be protective in animal models of OA. Aim We have previously shown that IL-1 down-regulated PPARg expression in OA chondrocytes. In the present study we will investigate the mechanisms underlying this effect of IL-1. Methods Chondrocytes were stimulated with IL-1, and the level of PPARg and Egr-1 protein and mRNA were evaluated using Western blotting and real-time reverse-transcription polymerase chain reaction, respectively. The PPARg promoter activity was analyzed in transient transfection experiments. Egr-1 recruitment to the PPARg promoter was evaluated using chromatin immunoprecipitation (ChIP) assays. Small interfering RNA (siRNA) approaches were used to silence Egr-1 expression. Results We demonstrated that the suppressive effect of IL-1 on PPARg expression requires de novo protein synthesis and was concomitant with the induction of the transcription factor Egr-1. ChIP analyses revealed that IL-1 induced Egr-1 recruitment at the PPARg promoter. IL-1 inhibited the activity of PPARg promoter and overexpression of Egr-1 potentiated the inhibitory effect of IL-1, suggesting that Egr-1 may mediate the suppressive effect of IL-1. Finally, Egr-1 silencing with small interfering RNA blocked IL-1-mediated down-regulation of PPARg expression. Conclusion These results indicate that Egr-1 contributes to IL-1mediated down-regulation of PPARg expression in OA chondrocytes and suggest that this pathway could be a potential target for pharmacologic intervention in the treatment of OA and possibly other arthritic diseases.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.